ArticleCancer communications (London, England)2025
Loss of SMARCB1 evokes targetable epigenetic vulnerabilities in epithelioid sarcoma.
Jia Xiang Jin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it